TELUS Proprietary
2
1. Terminology and background
2. Key results
3. Drug type utilization
4. Managed plans vs non-managed plans
5. Therapeutic category analysis
6. Product analysis
7. Specialty and biosimilar drug analysis
8. Analysis of targeted classes
9. Summary
10. Appendix
Content outline
